Skip to main content
Log in

Regional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT study

  • Short Communication
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

Hybrid imaging combining single photon emission computed tomography (SPECT) with 131I and X-ray computed tomography (CT) performed at radioablation (RA) for thyroid carcinoma more accurately detects regional lymph node metastases (LNM) than does planar imaging. In this bicentric prospective study we used hybrid imaging in conjunction with histopathological examination to measure LNM frequency in a consecutive group of patients referred for RA due to stage T1 papillary thyroid carcinoma (PTC).

Methods

At the Departments of Nuclear Medicine of the Ludwig Maximilian University of Munich and the Friedrich Alexander University of Erlangen-Nuremberg SPECT/spiral CT is routinely performed in all PTC subjects at the time of RA. Screening of our SPECT/CT databases for PTC patients with T1 histology produced 98 patients from Munich and 53 patients from Erlangen, including 96 of 151 patients with microcarcinoma. In 69 patients of the entire group, cervical lymph node dissection had been performed, whereas nodal staging in the remaining 82 subjects was based on SPECT/CT.

Results

LNM incidence in the whole group was 26% [95% confidence interval (CI): 20–33%] versus 22% (95% CI: 15–31%) in the microcarcinoma subgroup. SPECT/CT was more accurate in 24.5% of our patients than planar imaging with regard to nodal staging.

Conclusion

LNM occurs in one quarter of all patients with T1 PTC, and also in the subset with microcarcinoma. Performing 131I SPECT/CT, either with therapeutic or diagnostic radioactivities, directly after thyroidectomy should provide more accurate staging of T1 PTC, thus facilitating optimal therapeutic management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787–803.

    Article  CAS  PubMed  Google Scholar 

  2. Greene FI, Page LI, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging handbook. New York: Springer; 2002.

    Book  Google Scholar 

  3. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer 2003;98:31–40.

    Article  PubMed  Google Scholar 

  4. Dietlein M, Moka D, Scheidhauer K, Schmidt M, Theissen P, Voth E, et al. Follow-up of differentiated thyroid cancer: comparison of multiple diagnostic tests. Nucl Med Commun 2000;21(11):991–1000.

    Article  CAS  PubMed  Google Scholar 

  5. Schmidt D, Szikszai A, Linke R, Bautz W, Kuwert T. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med 2009;50:18–23.

    Article  PubMed  Google Scholar 

  6. Wong KK, Zarzhevsky N, Cahill JM, Frey KA, Avram AM. Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma. Br J Radiol 2009;82:860–76. doi:10.1259/bjr/25645894.

    Article  CAS  PubMed  Google Scholar 

  7. Aide N, Heutte N, Rame JP, Rousseau E, Loiseau C, Henry-Amar M, et al. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer. J Clin Endocrinol Metab 2009;94(6):2075–84.

    Article  CAS  PubMed  Google Scholar 

  8. Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with confidence. 2nd ed. London: British Medical Journal Books; 2000.

  9. Pellegriti G, Scollo C, Lumera G, Regalbutto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004;89:3713–20.

    Article  CAS  PubMed  Google Scholar 

  10. Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Ghuzlan AA, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 2009;94:1162–7.

    Article  CAS  PubMed  Google Scholar 

  11. Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R, Fahey TJ. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 2009;19:473–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Paul Cumming for his thorough revision of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mona Mustafa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mustafa, M., Kuwert, T., Weber, K. et al. Regional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT study. Eur J Nucl Med Mol Imaging 37, 1462–1466 (2010). https://doi.org/10.1007/s00259-010-1408-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-010-1408-2

Keywords

Navigation